Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Cash & Current Investments (2010 - 2026)

Innoviva's (INVA) quarterly Cash & Current Investments came in at $603.1 million in Q1 2026, up 89.0% YoY from $319.1 million in Q1 2025, and up 9.46% on a QoQ basis from $550.9 million in Q4 2025.

Analysis

Innoviva (INVA) Cash & Current Investments (2010 - 2026) Analysis & Trends

Innoviva (INVA) has 17 years of Cash & Current Investments data on file, last reported at $603.1 million in Q1 2026.

  • Quarterly Cash & Current Investments rose 89.0% year-over-year to $603.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $603.1 million (up 89.0% YoY) and the FY2025 annual result came in at $550.9 million, up 80.66% from the prior year.
  • Cash & Current Investments climbed to $603.1 million in Q1 2026, from $550.9 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $603.1 million in Q1 2026 to a low of $144.0 million in Q1 2023.
  • A 5-year average of $299.5 million and a median of $283.6 million in 2022 frame the typical range for Cash & Current Investments.
  • Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 555.45% — and 2023, when it slumped 40.21%.
  • Tracing INVA's Cash & Current Investments over 5 years: stood at $291.0 million in 2022, then sank by 33.51% to $193.5 million in 2023, then soared by 57.59% to $305.0 million in 2024, then soared by 80.66% to $550.9 million in 2025, then gained by 9.46% to $603.1 million in 2026.
  • The last three Cash & Current Investments figures came in at $603.1 million (Q1 2026), $550.9 million (Q4 2025), and $476.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn 579.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 579.06 Mn
Mar 31, 2026 611.93 Mn
Dec 31, 2025 566.67 Mn
Sep 30, 2025 533.10 Mn
Jun 30, 2025 497.73 Mn
Mar 31, 2025 446.88 Mn
Dec 31, 2024 412.50 Mn
Sep 30, 2024 260.63 Mn
Jun 30, 2024 217.00 Mn
Mar 31, 2024 178.36 Mn
Dec 31, 2023 193.51 Mn
Sep 30, 2023 180.00 Mn
Jun 30, 2023 173.03 Mn
Mar 31, 2023 144.05 Mn
Dec 31, 2022 291.05 Mn
Sep 30, 2022 301.07 Mn
Jun 30, 2022 283.58 Mn
Mar 31, 2022 216.80 Mn
Dec 31, 2021 201.53 Mn
Sep 30, 2021 135.12 Mn